dummies
 

Suchen und Finden

Titel

Autor/Verlag

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Osteoporosis in Men - The Effects of Gender on Skeletal Health

Eric S. Orwoll, John P. Bilezikian, Dirk Vanderschueren

 

Verlag Elsevier Reference Monographs, 2009

ISBN 9780080923468 , 764 Seiten

2. Auflage

Format PDF, ePUB, OL

Kopierschutz DRM

Geräte

155,00 EUR

  • Zuweisermarketing für niedergelassene Spezialisten - Allgemeinmediziner professionell gewinnen und binden
    Re-Institutionalisierung statt De-Institutionalisierung in der Behindertenhilfe - Neubestimmung der Funktion von Wohneinrichtungen für erwachsene Menschen mit geistiger Behinderung
    Obesity Prevention - The Role of Brain and Society on Individual Behavior
    Foundations of Regenerative Medicine - Clinical and Therapeutic Applications
    Analysis of Complex Disease Association Studies - A Practical Guide
    Spinal Imaging - Diagnostic Imaging of the Spine and Spinal Cord
    Health-Care Telematics in Germany - Design and Application of a Security Analysis Method
    Percutaneous Tumor Ablation in Medical Radiology
  • Neurological and Psychiatric Disorders
    Autonomy and Human Rights in Health Care - An International Perspective
    Lung Pathology
    Therapiehandbuch Gynäkologie und Geburtshilfe
    Psychological Challenges to Obstetrics and Gynecology - The Clinical Management
    Dopplersonographie in Geburtshilfe und Gynäkologie
    Personalmanagement im Gesundheitsbetrieb - Betriebswirtschaft für das Gesundheitswesen
    Immobilienwirtschaftliche Bewertung von Krankenhäusern nach Einführung der DRG
 

 

Front Cover

1

Osteoporosis in Men: The Effects of Gender on Skeletal Health

4

Copyright Page

5

Contents

6

Contributors

10

Foreword

14

Preface

16

SECTION 1 Essentials of Bone Biology

18

CHAPTER 1 The Biochemistry of Bone: Composition and Organization

20

INTRODUCTION

20

BONE ORGANIZATION

20

BONE COMPOSITION: THE BONE COMPOSITE

22

HOW BONES CHANGE WITH AGE

26

ACKNOWLEDGMENTS

27

References

27

CHAPTER 2 Bone Remodeling: Cellular Activities in Bone

32

INTRODUCTION

32

CELLULAR MECHANISM OF BONE REMODELING

32

PHYSIOLOGICAL FUNCTIONS OF BONE REMODELING

37

VARIATION IN BONE REMODELING ACTIVITY THROUGHOUT THE SKELETON

38

References

39

CHAPTER 3 Assessment of Bone Turnover in Men Using Biochemical Markers

42

INTRODUCTION

42

NEW BIOCHEMICAL MARKERS OF BONE METABOLISM AND NEW ASSAYS

42

NEW TECHNOLOGIES FOR DISCOVERY AND ASSAY BONE MARKERS

46

FACTORS INFLUENCING BTM LEVELS IN MEN

46

CLINICAL APPLICATIONS OF BONE TURNOVER MARKERS IN MALE OSTEOPOROSIS

48

EFFECT OF ANTI-OSTEOPOROTIC TREATMENT ON BTM IN MEN

50

CONCLUSION

53

References

53

CHAPTER 4 Fundamentals of Mineral Homeostasis

58

INTRODUCTION

58

TOTAL BODY STORES OF ESSENTIAL MINERALS

58

EXTRACELLULAR MINERAL METABOLISM – CIRCULATING LEVELS

59

INTRACELLULAR MINERAL METABOLISM

64

MINERAL ION BALANCE

65

SUMMARY

66

References

67

CHAPTER 5 The Mechanical Properties of Bone

68

INTRODUCTION

68

THE IDEA OF HIERARCHY IN BONE MECHANICS

68

ANATOMICAL STRUCTURAL EFFECT

69

ULTRASTRUCTURE AND MICROSTRUCTURE AND EFFECTS ON MECHANICAL PROPERTIES

75

ULTRASTRUCTURE AND BONE MECHANICAL PROPERTIES

75

STRAIN RATE, FRACTURE PROPAGATION TOUGHNESS AND FATIGUE

79

THE COMPLETE DEPENDENCE ON DAMAGE REPAIR FOR MECHANICAL FUNCTION

82

References

82

CHAPTER 6 Essentials of Bone Biology: Assessment of Bone Architecture

86

INTRODUCTION

86

DXA AND RADIOGRAPHIC IMAGING

87

COMPUTED TOMOGRAPHY (CT)

88

ASSESSMENT OF BONE MINERAL DENSITY: QUANTITATIVE COMPUTED TOMOGRAPHY (QCT)

89

MEASUREMENT OF STRUCTURE AND BMD USING VOLUMETRIC CT IMAGES OF THE SPINE AND HIP

89

FINDINGS BASED ON VOLUMETRIC QCT ANALYSES

90

3D QCT OF THE VERTEBRAE

91

FINITE ELEMENT MODELING (FEM)

92

MICROCT METHODS

93

CONCLUSION

94

References

95

SECTION 2 Development and Growth of the Male Skeleton

100

CHAPTER 7 Skeletal Growth in Males

102

INTRODUCTION

102

GROWTH IN STATURE

102

GROWTH IN BONE STRUCTURE

103

SKELETAL FRAGILITY HAS ITS ORIGIN EARLY IN LIFE

105

MODELING AND REMODELING – MACHINERY OF TRACKING

106

BONE GROWTH AND GH-IGF-I/SEX HORMONES

106

SUMMARY

107

References

107

CHAPTER 8 Pubertal Growth of the Male Skeleton

112

INTRODUCTION

112

SKELETAL MATURATION

112

BONE MEASUREMENT TECHNIQUES IN CHILDREN

113

SKELETAL CHANGES DURING PUBERTY

115

PEAK BONE MASS

117

CONCLUSION

117

References

118

CHAPTER 9 The Effects of Sex Steroids on Bone Growth

122

INTRODUCTION

122

LONGITUDINAL AND RADIAL BONE GROWTH

122

BONE MASS ACQUISITION DURING CHILDHOOD AND ADOLESCENCE

124

CHANGES IN BONE SIZE BY PERIOSTEAL EXPANSION DURING GROWTH

126

RELEVANT CLINICAL OBSERVATIONS ON THE SEX STEROIDS' EFFECT ON BONE GROWTH

131

CONCLUSIONS

132

References

132

CHAPTER 10 Nutritional Basis of Skeletal Growth

136

INTRODUCTION

136

ASSESSING THE ROLE OF NUTRITION IN SKELETAL ACQUISITION

136

RELATIVE ROLE OF NUTRITION IN SKELETAL REQUISITION

137

MICRONUTRIENTS AND BONE GROWTH

138

DIETARY PATTERNS AND BONE GROWTH

141

DIET AND EXERCISE INTERACTIONS

142

NUTRITION AND PEDIATRIC DISORDERS

142

CONCLUSIONS

143

References

144

CHAPTER 11 Physical Activity and Skeletal Growth

148

INTRODUCTION

148

HOW DOES BONE ADAPT TO PHYSICAL ACTIVITY?

149

HOW TO MEASURE BONE ADAPTATION TO PHYSICAL ACTIVITY

150

WHAT TYPES OF PHYSICAL ACTIVITY PROMOTE BONE STRENGTH?

150

HOW DOES PHYSICAL ACTIVITY INFLUENCE THE NORMAL PATTERN OF BONE ACCRUAL IN BOYS?

150

WHAT HAVE WE LEARNED FROM CROSS-SECTIONAL STUDIES?

151

PROSPECTIVE OBSERVATIONAL STUDIES

152

WHAT HAVE WE LEARNED FROM EXERCISE INTERVENTION STUDIES?

153

DO THE BENEFITS OF PHYSICAL ACTIVITY PERSIST?

159

SUMMARY AND CONCLUSION

160

References

161

SECTION 3 Skeletal Genetics

164

CHAPTER 12 The Genetics of Peak Bone Mass

166

INTRODUCTION

166

LINKAGE STUDIES

168

ASSOCIATION STUDIES

170

ANIMAL STUDIES

175

References

177

SECTION 4 Aging and the Male Skeleton

182

CHAPTER 13 Age-related Changes in Bone Remodeling and Microarchitecture

184

INTRODUCTION

184

THE PROCESS AND PURPOSE OF BONE MODELING AND REMODELING

184

ABNORMALITIES IN BONE REMODELING DURING AGING

186

BONE LOSS DURING YOUNG ADULTHOOD, MENOPAUSE AND ADVANCED AGE

188

REDUCED PERIOSTEAL BONE FORMATION IN ADULTHOOD

190

SEX DIFFERENCES IN TRABECULAR AND CORTICAL BONE LOSS AND FRACTURE RATES

191

SUMMARY AND CONCLUSION

192

References

193

CHAPTER 14 Markers of Bone Remodeling and the Aging Skeleton

196

INTRODUCTION

196

AGE-RELATED CHANGES IN BONE MARKER LEVELS

196

BONE MARKERS, BONE LOSS AND FRACTURE RISK IN AGING MEN

198

THE RESPONSE OF BONE TURNOVER MARKERS TO PHARMACOLOGICAL INTERVENTIONS IN AGING MEN

199

CONCLUSION

199

References

199

CHAPTER 15 Alterations in Mineral Metabolism in the Aging Male

202

INTRODUCTION

202

CELLULAR CHANGES

202

AGE-RELATED HORMONAL CHANGES IN MINERAL METABOLISM

202

SUMMARY

207

References

208

CHAPTER 16 Changes in Bone Size and Geometry with Aging

210

RADIAL BONE GROWTH IN CHILDREN AND ADOLESCENTS

210

RADIAL BONE GROWTH DURING AGING

211

DETERMINANTS OF THE BONE SIZE AND AGE-RELATED CHANGES IN BONE GEOMETRY

212

AGE-RELATED CHANGES IN BONE SHAPE

216

WHY DO BONES GROW IN WIDTH AFTER CESSATION OF THE GROWTH IN LENGTH?

217

METHODOLOGICAL LIMITATIONS OF THE STUDIES ON THE AGE-RELATED CHANGES IN BONE SIZE

219

GENERAL CONCLUSIONS

220

ACKNOWLEDGMENTS

220

References

220

CHAPTER 17 Aging and Bone Loss

224

INTRODUCTION

224

UNDERSTANDING BONE LOSS WITH AGING IN MEN

224

QUANTIFYING BONE LOSS IN MEN

224

BONE LOSS WITH AGING IN MEN

227

FACTORS CONTRIBUTING TO BONE LOSS

230

PRACTICAL SCREENING FOR SIGNIFICANT MALE BONE LOSS AND OSTEOPOROSIS

233

SUMMARY

234

References

234

CHAPTER 18 The Effect of Age on Material Properties

238

INTRODUCTION

238

BIOMECHANICAL MATERIAL PROPERTIES OF THE SKELETON

238

CHANGES TO BIOMECHANICAL MATERIAL PROPERTIES WITH AGE

240

MINERAL EFFECTS IN AGE-RELATED MATERIAL PROPERTY ALTERATIONS

241

COLLAGEN EFFECTS IN AGE-RELATED MATERIAL PROPERTY ALTERATIONS

243

MICRODAMAGE EFFECTS IN AGE-RELATED MATERIAL PROPERTY ALTERATIONS

244

CONCLUSIONS

245

References

246

SECTION 5 Nutritional Issues

250

CHAPTER 19 Calcium, Bone Strength and Fractures

252

INTRODUCTION

252

CALCIUM PHYSIOLOGY

252

CALCIUM REQUIREMENTS

253

CALCIUM AND BONE STRENGTH

254

EVIDENCE OF CALCIUM'S EFFECT ON BMD IN ADULTS

254

CALCIUM AND FRACTURES

255

CHILDREN AND CALCIUM

256

CONCLUSION

257

References

257

CHAPTER 20 Vitamin D and Bone

260

INTRODUCTION

260

ORIGIN, METABOLISM, ACTION AND MODE OF ACTION

260

VITAMIN D AND BONE: BASIC MECHANISMS

261

VITAMIN D AND BONE: CLINICAL ASPECTS

263

SURROGATE ENDPOINTS

263

HARD ENDPOINTS

264

CHOICE OF VITAMIN D PRODUCT AND TREATMENT REGIMEN

266

OPTIMAL VITAMIN D STATUS VERSUS PRESENT WORLD REALITY

266

References

267

CHAPTER 21 Role of Dietary Protein in Bone Growth and Bone Loss

272

INTRODUCTION

272

DIETARY PROTEIN AND BONE GROWTH

272

DAIRY PRODUCTS AND BONE GROWTH

273

DIETARY PROTEIN AND BONE MINERAL MASS

274

DIETARY PROTEIN AND FRACTURE RISK

274

DIETARY PROTEIN AND BONE METABOLISM

275

EFFECTS OF PROTEIN INSUFFICIENCY CORRECTION

277

ACKNOWLEDGMENT

278

References

278

SECTION 6 Sex Steroids and the Skeleton in Men

284

CHAPTER 22 The Molecular Biology of Sex Steroids in Bone: Similarities and Differences among the Sexes

286

INTRODUCTION

286

GENERAL ASPECTS OF THE MECHANISMS OF SEX STEROID ACTION IN BONE CELLS

287

ESTROGEN AND ANDROGENS CONTROL OSTEOBLASTOGENESIS AND OSTEOCLASTOGENESIS

287

ESTROGEN AND ANDROGENS CONTROL BONE CELL SURVIVAL

290

OXIDATIVE STRESS AND THE CONTROL OF BONE MASS

291

ESTROGEN RECEPTOR SIGNALING AND MECHANOTRANSDUCTION

292

EFFECTS ON THE PERIOSTEUM

293

T CELLS AND THE REGULATION OF BONE RESORPTION

293

ER AND AR KNOCKOUT MODELS

294

References

294

CHAPTER 23 Estrogen and the Skeleton – Rodents

300

INTRODUCTION

300

ESTROGENS AND BONE GROWTH IN MALES

300

ESTROGENS AND BONE MAINTENANCE IN MALES

302

References

302

CHAPTER 24 Estrogen and the Skeleton – Humans

306

INTRODUCTION

306

ESTROGEN AND BONE GROWTH IN MEN

306

ESTROGEN AND BONE MAINTENANCE IN MEN

307

ESTROGEN AND FRACTURES IN MEN

308

References

309

CHAPTER 25 Androgens and Bone: Basic Aspects

312

INTRODUCTION

312

ANDROGENS AND THE ROLE OF ANDROGEN METABOLISM IN BONE

312

DHT

312

MECHANISMS OF ANDROGEN ACTION IN BONE: THE ANDROGEN RECEPTOR

315

MOLECULAR MECHANISMS OF ANDROGEN ACTION IN BONE CELLS: THE AR

315

LOCALIZATION OF AR EXPRESSION IN OSTEOBLASTIC POPULATIONS

316

REGULATION OF AR EXPRESSION

318

EFFECTS OF ANDROGENS ON THE PROLIFERATION AND DIFFERENTIATION OF OSTEOBLASTIC CELLS

320

ANDROGEN EFFECTS ON OSTEOCLASTS AND OTHER CELLS

322

ANDROGEN EFFECTS ON BONE: ANIMAL STUDIES

323

EFFECTS ON BONE GROWTH DURING SKELETAL DEVELOPMENT

323

EFFECTS ON EPIPHYSEAL FUNCTION DURING DEVELOPMENT

323

EFFECTS ON BONE MASS IN GROWING MALE ANIMALS: ANIMAL MODELS OF ALTERED ANDROGEN RESPONSIVENESS

324

EFFECTS ON THE PERIOSTEUM: THE ROLE OF AR VERSUS AROMATIZATION OF TESTOSTERONE

326

EFFECTS ON BONE MASS IN ADULTS: EFFECTS OF CASTRATION IN YOUNG AND ADULT ANIMALS

326

ANDROGENS IN THE FEMALE ANIMAL

328

EFFECTS OF REPLACEMENT SEX STEROIDS AFTER CASTRATION

328

SUMMARY

329

References

329

CHAPTER 26 Androgens and the Skeleton – Humans

336

INTRODUCTION

336

ANDROGENS AND BONE METABOLISM IN NORMAL MEN

336

BONE MINERAL DENSITY IN MEN WITH HYPOGONADISM OR OTHER DISORDERS OF ANDROGEN ACTION

341

EFFECTS OF ANDROGEN THERAPY ON SKELETAL INTEGRITY IN MEN

344

SUMMARY AND FUTURE DIRECTIONS

347

References

347

CHAPTER 27 Androgen Effects on the Skeletal Muscle

352

INTRODUCTION

352

EPIDEMIOLOGICAL STUDIES DEMONSTRATING THE RELATIONSHIP OF SERUM TESTOSTERONE CONCENTRATIONS AND MUSCLE MASS AND PHYSICAL FUNCTION

352

THE EFFECTS OF EXPERIMENTAL LOWERING OF ENDOGENOUS TESTOSTERONE CONCENTRATIONS ON BODY COMPOSITION

353

THE EFFECTS OF PHYSIOLOGIC TESTOSTERONE REPLACEMENT IN MODELS OF ANDROGEN DEFICIENCY

353

TESTOSTERONE DOSE-RESPONSE RELATIONSHIPS IN YOUNG AND OLDER MEN

353

INTERACTIVE EFFECTS OF TESTOSTERONE AND RESISTANCE EXERCISE TRAINING

354

RANDOMIZED CLINICAL TRIALS OF TESTOSTERONE IN OLDER MEN WITH LOW OR LOW NORMAL TESTOSTERONE LEVELS

354

EFFECTS OF ANDROGEN REPLACEMENT ON BODY COMPOSITION AND MUSCLE PERFORMANCE IN MEN WITH CHRONIC ILLNESS

355

TESTOSTERONE EFFECTS ON FATIGUE/ENERGY, SENSE OF WELL-BEING AND QUALITY OF LIFE

357

REACTION TIME

357

MECHANISMS OF TESTOSTERONE EFFECTS ON SKELETAL MUSCLE

357

HOW TESTOSTERONE EFFECTS ON THE SKELETAL MUSCLE–BONE UNIT MAY AFFECT FRACTURE RISK

359

ACHIEVING TISSUE SELECTIVITY OF TESTOSTERONE EFFECTS

359

CONCLUSION

360

References

360

SECTION 7 Fractures in Men

366

CHAPTER 28 Epidemiology of Fractures

368

INTRODUCTION

368

OVERALL FRACTURE INCIDENCE IN MEN

368

DIFFERENCES IN FRACTURE INCIDENCE PATTERNS BETWEEN MEN AND WOMEN

368

OSTEOPOROTIC FRACTURES IN MEN

369

FRACTURES AT SPECIFIC BONE SITES

370

BONE DENSITY AND FRACTURE RISK IN MEN

373

SUMMARY

374

References

374

CHAPTER 29 Individualized Prognosis of Fracture in Men

378

MAGNITUDE OF THE PROBLEM

378

RISK FACTORS OF FRAGILITY FRACTURE

380

PROGNOSIS

382

CONCLUSION

386

References

386

CHAPTER 30 Physical Activity, Physical Function and Fall and Fracture Risk in Older Men

392

INTRODUCTION

392

PHYSICAL ACTIVITY

392

PHYSICAL FUNCTION AND PERFORMANCE

395

References

399

CHAPTER 31 Economic Impact of Osteoporotic Fractures (versus Women)

402

BACKGROUND

402

COST OF ILLNESS STUDIES

403

GENDER DIFFERENCES IN ECONOMIC IMPACT

403

METHODOLOGIC APPROACHES TO DEFINING COST OF ILLNESS

403

ECONOMIC IMPACT OF OSTEOPOROTIC FRACTURES

405

SUMMARY

409

References

409

CHAPTER 32 Adverse Health Outcomes in Men with Osteoporosis

412

INTRODUCTION

412

MORBIDITY IN MEN AFTER OSTEOPOROTIC FRACTURES

412

PSYCHOSOCIAL CONSEQUENCES OF OSTEOPOROTIC FRACTURES IN MEN

414

MORTALITY IN MEN AFTER OSTEOPOROTIC FRACTURE

415

CONCLUSIONS

416

References

416

SECTION 8 Metabolic Bone Disease in Men

420

CHAPTER 33 Idiopathic Osteoporosis

422

INTRODUCTION

422

DIAGNOSIS

422

CLINICAL PRESENTATION AND PHENOTYPE

425

PHYSIOPATHOLOGY AND GENETICS

426

TREATMENT

427

AREAS FOR FURTHER RESEARCH

428

ACKNOWLEDGMENTS

428

References

428

CHAPTER 34 Glucocorticoid-induced Osteoporosis

432

EPIDEMIOLOGY

432

PATHOPHYSIOLOGY

432

DIAGNOSIS

434

THERAPY

435

CONCLUSIONS

436

References

436

CHAPTER 35 Testicular Dysfunction

440

INTRODUCTION

440

GONADAL STEROID ACTION

440

SKELETAL HEALTH IN ANDROGEN DEFICIENCY AT VARIOUS AGES

442

References

447

CHAPTER 36 Alcohol Use and Bone Health in Men

452

INTRODUCTION

452

ALCOHOL PHYSIOLOGY

452

EPIDEMIOLOGY

452

MODERATION; IS LESS MORE?

453

ALCOHOL IMPACTS ON BONE AND CALCIUM HOMEOSTASIS

453

BONE MINERAL DENSITY (BMD)

454

ALCOHOL, FALLS AND FRACTURES IN MEN

455

ISSUES CONFOUNDING STUDIES OF ALCOHOL USE

456

CONCLUSION

457

References

457

CHAPTER 37 Transplantation Osteoporosis

460

INTRODUCTION

460

SKELETAL EFFECTS OF IMMUNOSUPPRESSIVE DRUGS

460

EFFECT OF TRANSPLANTATION ON BONE AND MINERAL METABOLISM

461

EVALUATION AND MANAGEMENT OF CANDIDATES FOR TRANSPLANTATION

464

PREVENTION OF TRANSPLANTATION OSTEOPOROSIS (TABLE 37.3)

465

SUMMARY AND CONCLUSIONS

466

References

467

CHAPTER 38 Management of Fractures in Men with Impaired Renal Function

470

INTRODUCTION

470

DIAGNOSIS OF OSTEOPOROSIS IN STAGE 1–3 CHRONIC KIDNEY DISEASE

470

DIAGNOSIS OF OSTEOPOROSIS IN STAGE 5–5D CKD

472

BIOCHEMICAL MARKERS OF BONE METABOLISM

472

QUANTITATIVE BONE HISTOMORPHOMETRY

473

TREATMENT OF OSTEOPOROSIS IN CKD

474

CONCLUSIONS

478

References

478

CHAPTER 39 Primary Hyperparathyroidism in Men

482

INTRODUCTION

482

EPIDEMIOLOGY

482

ETIOLOGY

484

PATHOLOGY

484

SIGNS AND SYMPTOMS

484

CLINICAL PRESENTATION

486

EVALUATION AND DIAGNOSIS

486

PARATHYROID IMAGING

487

NATURAL HISTORY OF MILD PHPT

488

SURGICAL TREATMENT

488

CLINICAL COURSE AFTER SURGERY

490

MEDICAL MANAGEMENT

491

SUMMARY

493

References

493

CHAPTER 40 Hypercalciuria

496

INTRODUCTION

496

CLINICAL BONE DISEASE

496

DEFINITION OF HYPERCALCIURIA

497

SERUM 1,25D LEVELS

497

RELATIONSHIP BETWEEN URINE CA AND BONE LOSS

498

BONE PATHOGENESIS

499

CALCIUM METABOLISM

500

DIETARY FACTORS

501

TREATMENT

502

References

504

CHAPTER 41 The Skeletal Phenotype of the Male Athlete

508

INTRODUCTION

508

PRINCIPLES OF LOADING

508

MEASUREMENT OF BONE LOADING AND BONE MASS

508

HORMONAL DETERMINANTS OF SKELETAL MASS

509

ENVIRONMENTAL AND NUTRITIONAL DETERMINANTS OF SKELETAL HEALTH IN MALE ATHLETES

511

COMPARISON OF MALE ATHLETES TO THE FEMALE TRIAD

513

USE OF ANDROGENIC AND ANABOLIC STEROIDS IN ATHLETICS

514

BONE MASS AND STRESS FRACTURES IN MALE ATHLETES: A REVIEW OF THE LITERATURE

514

CONCLUSIONS

518

References

518

CHAPTER 42 Inherited and Related Disorders of Bone Matrix Synthesis in Men

522

INTRODUCTION

522

INHERITED DEFECTS IN COLLAGEN SYNTHESIS (TABLE 42.2)

523

MARFAN SYNDROME AND OSTEOPOROSIS

529

HYPOPHOSPHATASIA IN THE ADULT MALE

531

FIBROUS DYSPLASIA IN ADULT MALES

532

OSTEOPOROSIS RELATED TO INHERITED DEFECTS IN COPPER TRANSPORT: MENKES' DISEASE, OCCIPITAL HORN SYNDROME, WILSON DISEASE

533

HEMOCHROMATOSIS AND OSTEOPOROSIS IN MEN

534

HOMOCYSTINURIA

535

INHERITED DEFECTS IN NEUROTROPIC FACTORS RELATED TO BONE

535

References

536

SECTION 9 Diagnostic Approach

540

CHAPTER 43 Dual-Energy X-ray Absorptiometry (DXA) in Men

542

INTRODUCTION/ BACKGROUND

542

DUAL-ENERGY X-RAY (DXA) TECHNOLOGY

542

UNDERSTANDING DXA RESULTS

543

WHAT SKELETAL SITES TO MEASURE

544

PITFALLS IN DXA

544

DXA NORMATIVE DATABASES

546

CLINICAL USE OF DXA: DIAGNOSIS, MONITORING AND FRACTURE RISK ASSESSMENT

548

INDICATIONS FOR DXA TESTING IN MEN

552

VERTEBRAL FRACTURE ASSESSMENT

553

SUMMARY

554

References

555

CHAPTER 44 Quantitative Ultrasound Diagnosis of Osteoporosis in Men

558

PRINCIPLES OF QUANTITATIVE ULTRASOUND

558

USE OF QUS TO PREDICT FRACTURE IN MEN

558

USE OF QUS TO PREDICT WHEN TO OBTAIN DXA IN MEN

559

MONITORING THERAPY WITH QUS

560

CONCLUSIONS

560

References

561

CHAPTER 45 Advanced Structural Assessment of Bone Using CT and MRI

564

INTRODUCTION

564

QCT AND MDCT-BASED STRUCTURAL ANALYSES IN THE DIAGNOSTICS AND MONITORING OF OSTEOPOROSIS PATIENTS

565

?CT IMAGING AND INDIVIDUAL TRABECULAE SEGMENTATION (ITS)-BASED MORPHOLOGICAL ANALYSIS

568

HIGH RESOLUTION PERIPHERAL QUANTITATIVE CT (HR-PQCT)

571

MAGNETIC RESONANCE IMAGING (MRI)

572

IMAGE-BASED FEA

575

CONCLUSION

577

ACKNOWLEDGMENTS

577

References

578

CHAPTER 46 Diagnostic Approach: Vertebral Fracture Assessments

582

INTRODUCTION

582

PROBLEMS ASSOCIATED WITH IDENTIFICATION OF PREVALENT AND INCIDENT VF

582

WHY ARE VERTEBRAL FRACTURES RELEVANT IN MEN?

583

ESTABLISH THE PRESENCE OF VF: WHEN IS A DEFORMITY A TRUE OSTEOPOROTIC FRACTURE?

584

IMAGING APPROACHES FOR THE IDENTIFICATION OF VF

584

ADDITIONAL AREAS FOR RESEARCH

590

CONCLUSIONS

590

References

590

CHAPTER 47 The Use of Bone Biopsies in the Diagnosis of Male Osteoporosis

594

INTRODUCTION

594

AGE-DEPENDENT CHANGES IN BONE PROPERTIES IN FEMALES

594

CHANGES IN BONE REMODELING WITH AGE IN MALES

595

CHANGES IN BONE STRUCTURE WITH AGING IN MALES AND FEMALES

595

HISTOMORPHOMETRY IN MALE OSTEOPOROSIS

595

SECONDARY OSTEOPOROSIS

597

INDICATIONS FOR BONE BIOPSIES IN MALE OSTEOPOROSIS

601

FUTURE ASPECTS

601

CONCLUSION

601

References

602

CHAPTER 48 Overall Approach to the Evaluation and Treatment of Osteoporosis in Men

606

DIAGNOSTIC CONSIDERATIONS

606

TREATMENT CONSIDERATIONS

611

References

615

SECTION 10 Therapy

620

CHAPTER 49 Diagnostic Thresholds for Osteoporosis in Men

622

INTRODUCTION

622

DIAGNOSIS OF OSTEOPOROSIS

622

DIAGNOSTIC CRITERIA FOR MEN

623

NORMATIVE REFERENCE RANGES

624

LIMITATIONS

627

References

627

CHAPTER 50 Cost-Effectiveness of Interventions to Reduce Osteoporosis-Related Fractures in Men: Current Data, Controversies, and Challenges

630

INTRODUCTION

630

CHARACTERISTICS OF GOOD HEALTH ECONOMIC MODELING STUDIES

631

REVIEW OF COST-EFFECTIVENESS STUDIES IN MEN

632

CONTROVERSIES AND CHALLENGES IN HEALTH ECONOMIC MODELING OF FRACTURE PREVENTION STRATEGIES

640

CONCLUSIONS

642

References

642

CHAPTER 51 Nutritional Therapy for Skeletal Health in Men

646

INTRODUCTION

646

MACRONUTRIENTS

646

CALCIUM AND VITAMIN D

647

OTHER NUTRIENTS

649

CONCLUSION

649

References

649

CHAPTER 52 Exercise Programs for Patients with Osteoporosis

652

GOALS OF EXERCISE IN PATIENTS WITH OSTEOPOROSIS

652

PITFALLS IN ASSESSING EXERCISE INTERVENTIONS

653

THE ROLE OF PHYSICS, ANATOMY AND PHYSIOLOGY FOR DESIGNING AND ASSESSING EXERCISE INTERVENTIONS

653

BONE STRENGTH AND FALL RISK: TWO DIFFERENT GOALS, TWO DIFFERENT RELATIONSHIPS TO MUSCLE

655

BIPEDAL LOCOMOTION AND ONE-LEG-STANDING

656

THE SKELETON AS TENSEGRITY STRUCTURE

656

DXA–BMD AS OUTCOME PARAMETER OF EXERCISE INTERVENTIONS

657

RELATIONSHIPS BETWEEN MUSCLE AND BONE: THE MUSCLE–BONE UNIT

657

CORRELATIONS OF PHYSICAL ACTIVITY AND LOCOMOTOR PERFORMANCES WITH FRACTURES, FALLS AND ONSET OF DISABILITY

658

SARCOPENIA AND AGE-ASSOCIATED FUNCTIONAL DECLINE

659

OSTEOPOROSIS-RELATED FRACTURES AND FALLS

660

EXERCISE INTERVENTIONS AND BONE STRENGTH

661

EFFECT OF EXERCISE INTERVENTION ON MUSCLE STRUCTURE AND MUSCLE FUNCTION

662

EFFECT OF EXERCISE INTERVENTIONS ON RISK FACTORS FOR FALLS, FRACTURES AND ONSET OF DISABILITY

662

EXERCISE INTERVENTIONS AND FALL PREVENTION

663

WHOLE BODY VIBRATION

663

RISK OF EXERCISES

663

RECOMMENDATIONS FOR DESIGNING AND PRESCRIBING EXERCISE PROGRAMS FOR PATIENTS WITH OSTEOPOROSIS

663

FUTURE DEVELOPMENTS AND DEMANDS

664

References

665

CHAPTER 53 Calcitonin: History, Physiology, Pathophysiology and Therapeutic Applications

670

INTRODUCTION

670

SYNTHESIS AND LOCALIZATION

670

STRUCTURE OF CALCITONIN AND ITS MEASUREMENTS

670

PHYSIOLOGICAL ROLE OF CALCITONIN

671

BIOLOGICAL EFFECTS OF CALCITONIN

673

CLINICAL PHARMACOLOGY

673

COMMERCIALLY AVAILABLE CALCITONIN PREPARATIONS

674

THERAPEUTIC USES

676

References

680

CHAPTER 54 Treatment of Male Osteoporosis with Bisphosphonates

684

INTRODUCTION

684

PHARMACOLOGY OF BISPHOSPHONATES

684

DO MEN RESPOND DIFFERENTLY TO BISPHOSPHONATES?

685

BISPHOSPHONATES IN MEN WITH PRIMARY OSTEOPOROSIS

687

BISPHOSPHONATES IN MEN WITH SECONDARY OSTEOPOROSIS

692

SPECIAL ISSUES RELATED TO TREATMENT OF MALE OSTEOPOROSIS WITH BPS

693

CONCLUSIONS

694

References

694

CHAPTER 55 Treatment of Male Osteoporosis with Parathyroid Hormone

698

INTRODUCTION

698

ANABOLIC ACTIONS OF PARATHYROID HORMONE

698

INDICATIONS FOR TERIPARATIDE USE

699

TERIPARATIDE IN MALE OSTEOPOROSIS

700

COMBINATION OR SEQUENTIAL THERAPY WITH PTH AND AN ANTI-RESORPTIVE AGENT

701

ANTI-RESORPTIVE USE PRIOR TO PTH THERAPY

702

CONSEQUENCES OF DISCONTINUING PTH THERAPY

702

SAFETY OF PTH

703

FUTURE CONSIDERATIONS

703

CONCLUSIONS

703

References

704

CHAPTER 56 Testosterone Therapy for Osteoporosis in Men

708

INTRODUCTION

708

THE MAGNITUDE OF THE PROBLEM

708

MARKERS OF FRACTURE RISK

708

MECHANISMS BY WHICH TESTOSTERONE INFLUENCES MUSCLE AND BONE

709

STUDIES ON THE ASSOCIATION BETWEEN TESTOSTERONE AND MUSCLE AND BONE IN MEN

709

DIAGNOSIS OF HYPOGONADISM/ANDROGEN DEFICIENCY

716

EPIDEMIOLOGY OF ANDROGEN DEFICIENCY AND CO-PREVALENCE WITH OSTEOPOROSIS

718

TESTOSTERONE PREPARATIONS

718

STRATEGIES TO MINIMIZE RISK OF ADVERSE EFFECTS

720

TESTOSTERONE ADMINISTRATION AND MONITORING

721

BMD

721

USE OF TESTOSTERONE THERAPY IN MEN AT RISK FOR OSTEOPOROSIS AND FRACTURE

722

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)

723

ACKNOWLEDGMENTS

723

References

723

CHAPTER 57 Future Therapies: Strontium, SERMs, SARMs and New Therapies on the Horizon

730

INTRODUCTION

730

STRONTIUM

730

SELECTIVE ESTROGEN RECEPTOR MODULATORS (SERMS)

733

SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)

736

NEW THERAPIES ON THE HORIZON

739

CONCLUSION

745

ACKNOWLEDGMENTS

745

Glossary of abbreviations

746

References

746

Index

750

A

750

B

751

C

751

D

752

E

752

F

752

G

753

H

753

I

754

K

754

L

754

M

754

N

754

O

755

P

755

Q

756

R

756

S

756

T

757

U

757

V

757

W

758

Y

758

Color Plates

760